NKCFO LLC’s Doximity DOCS Stock Holding History

NKCFO LLC’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-460	Closed	-$24K	–	108
2022 Q1	$24K	Buy	+460	New	+$23.2K	0.01%	111

Other funds holding DOCS

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

NKCFO LLC's DOCS Position: Q2 2022 in Review

NKCFO LLC sold out of Doximity (DOCS) in Q2 2022, closing a stake of 460 shares — an estimated $24K sold.

NKCFO LLC first reported a position in DOCS in Q1 2022 and held it in 1 quarter. The position peaked at $24K in Q1 2022. 247 funds tracked by Wall St. Rank hold DOCS as of Q2 2022.

NKCFO LLC reported no remaining Doximity position as of Q2 2022 after selling out during the quarter.
NKCFO LLC sold 460 Doximity shares in Q2 2022, an estimated $24K.
NKCFO LLC first reported a position in Doximity in Q1 2022 and held it in 1 quarter.
NKCFO LLC's Doximity position peaked at $24K in Q1 2022.
247 funds tracked by Wall St. Rank held Doximity as of Q2 2022.

Based on NKCFO LLC's 13F filing for Q2 2022, filed 8 Jul 2022.